Research-grade retatrutide vs prescription GLP-1 drugs. Enter your weekly dose and protocol duration to see exactly how much you save — and why retatrutide is the only option on the market.
Recommended Vial
30mg vial
You need 20mg/month · 30mg covers it
Monthly Cost
$330
vs Mounjaro over 3 Months
$2,079
in total savings choosing research-grade retatrutide
Research Retatrutide
30mg vial · your only option
/mo
$330
total
$990
Mounjaro
tirzepatide · prescription
/mo
$1,023
you save
$2,079
Wegovy
semaglutide · prescription
/mo
$1,349
you save
$3,057
Ozempic
semaglutide · prescription
/mo
$935
you save
$1,815
Zepbound
tirzepatide · prescription
/mo
$1,059
you save
$2,187
Retatrutide is not yet FDA-approved
Unlike tirzepatide or semaglutide, retatrutide has no approved prescription equivalent. Research-grade is your only option — meaning there is no prescription alternative to compare against. The savings above reflect what you avoid by not defaulting to an inferior GLP-1 or GLP-1/GIP drug.
Prescription prices sourced from GoodRx and manufacturer list pricing (2025–2026). Research peptide pricing based on current market rates. For informational purposes only. Not medical advice.